Dr. Themistocles Dassopoulos, MD

Dr. Dassopoulos practices at Baylor Scott & White SurgiCare - Dallas in Dallas, Texas.

Dr. Dassopoulos' NPI, 1326083148, was assigned on June 17, 2006. Dr. Dassopoulos graduated from The Warren Alpert Medical School of Brown University in 1991. Dr. Dassopoulos' Texas license number on file is Q0899.

Dr. Dassopoulos' primary practice is Baylor Scott & White SurgiCare - Dallas, at 3920 Worth Street, Dallas, TX 75246. The practice phone is (972) 961-1685.

Dr. Dassopoulos' primary practice is Baylor Scott & White SurgiCare - Dallas in Dallas, Texas. Dr. Dassopoulos is also affiliated with Baylor University Medical Center. The medical group on file is HealthTexas Provider Network (HTPN). Dmand AI also links Dr. Dassopoulos to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dassopoulos practices, 3 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Dassopoulos' primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Dassopoulos is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Dassopoulos' licenses on file in 4 states: Texas, Missouri, Maryland and Illinois.

Dmand AI lists chronic inflammatory bowel disease (IBD), colonoscopy, gastrointestinal bleeding and irritable bowel syndrome (IBS) among the conditions Dr. Dassopoulos treats.

CMS data shows 336 Medicare services from Dr. Dassopoulos across 9 procedure codes in 2024, for 125 Medicare patients. Medicare paid $22,214 for them.

CMS counts 125 Medicare patients who saw Dr. Dassopoulos in 2024. The largest group is 65 to 74, with 59 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 11% are also on Medicaid. Their average risk score is 2.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dassopoulos' median patient age at 45, with 49% women.

In 2024, Dr. Dassopoulos wrote 39 Medicare Part D claims for 15 patients. 77% of them were for generic drugs. CMS names the drug for 22 of them, across 2 drugs with 11 or more claims each, at $11,179 in total drug cost. In 2020, CMS named 71 claims across 4 drugs.

Dr. Dassopoulos accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 35 procedures of colonoscopy by Dr. Dassopoulos, more than 56% of the clinicians it reports for that procedure.

Dmand AI links 62 papers to Dr. Dassopoulos, published from 2003 to 2024. 2015 was the busiest year, with 3. The most frequent topics are Crohn Disease, Colitis, Ulcerative and Inflammatory Bowel Diseases. Dr. Dassopoulos has published most often in Inflamm Bowel Dis. Dr. Dassopoulos' most frequent co-authors are Steven Ross Brant, MD, Dermot P. McGovern, MD, PhD and Jean-Paul Achkar, MD.

Dmand AI links Dr. Dassopoulos to 1 clinical trial. Conditions studied include Colitis, Ulcerative and Colitis. Open Payments lists research payments to Dr. Dassopoulos that name 1 trial.

CMS Open Payments shows 528 general payments to Dr. Dassopoulos from 37 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 46% of the total. Merck Sharp & Dohme Corporation paid the most, $8,723. It also lists 2 research payments totaling $2,415 from 2016 to 2017, naming 1 clinical trial.

Dr. Dassopoulos graduated from The Warren Alpert Medical School of Brown University in 1991.

Dr. Dassopoulos is in network with 22 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.